Organon and Roche settle patent dispute:
This article was originally published in Clinica
Organon Teknika has settled all patent litigation relating to nucleic acid amplification technology with Swiss company Hoffmann-La Roche. As a result of the settlement, Dutch company Organon will be able to expand its NucliSens product line, which is based on NASBA RNA transcription amplification.
You may also be interested in...
Johnson & Johnson believes personalization via digital holds the key to smoking cessation success as it launches in the UK its app-supported Nicorette QuickMist SmartTrack product.
China’s Bio-Thera Solutions has ventured outside of its domestic market for the first time by filing an application for a biosimilar version of Avastin with the European Medicines Agency. The company has also revealed its timeline for a submission to the FDA.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.